2012 annual financial data
Marker Therapeutics 2012 Net margin
Marker Therapeutics 2012 net margin with verified reported values.
Direct answer
Net margin was Not calculable.
Operating income was -6,223,000 USD and net income was -5,858,000 USD.
Operating cash flow was -1,565,098 USD.
Get free Marker Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -6,223,000 USD
- Net income
- -5,858,000 USD
- Operating cash flow
- -1,565,098 USD